Company Filing History:
2 out of 180 
2 out of 1,342 
1 out of 1 Years Active: 2019-2025
Title: Younghwa Na: Innovator in Cancer and Pulmonary Fibrosis Treatment
Introduction
Younghwa Na is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of cancer treatment and pulmonary fibrosis through his innovative research and patented inventions. With a total of 2 patents, Na's work focuses on developing effective therapeutic compositions.
Latest Patents
One of Younghwa Na's latest patents is a composition for the prevention, amelioration, or treatment of cancer. This invention involves alpha-beta unsaturated aryl, heteroaryl, and cycloalkylene ketone compounds that are effective in inhibiting the growth of cancer cells and preventing metastasis. Another notable patent addresses methods for treating pulmonary fibrosis using chromenone derivatives. This composition alters heat shock protein 27 (HSP27) dimers, which helps prevent the harmful effects of irradiation-induced pulmonary fibrosis.
Career Highlights
Throughout his career, Younghwa Na has worked with esteemed institutions, contributing to advancements in medical research. His innovative approaches have garnered attention in the scientific community, particularly for their potential impact on cancer and pulmonary diseases.
Collaborations
Na has collaborated with various professionals in his field, including notable coworkers such as Yun-Sil Lee and Jae Ho Cho. His partnerships with institutions like Ewha University-Industry Collaboration Foundation and Yonsei University have further enhanced his research capabilities.
Conclusion
Younghwa Na's contributions to medical science through his patents and collaborations highlight his dedication to improving health outcomes. His innovative work continues to pave the way for advancements in cancer treatment and pulmonary fibrosis management.